Cross-Border Medicine Transportation in the EAEU Now Runs Entirely on EEC Council Decision No. 80
A distributor transporting a shipment of insulin from the Moscow region to Almaty today opens a single document containing the transportation requirements: Decision of the EEC Council No. 80. A year ago, for that same route, they had to keep two separate acts in mind, and the requirements in them did not always sound identical.
The gap has not closed completely. Logistics SOPs (standard operating procedures) and contracts with carriers still contain references to the order that ceased to be effective in May 2025. For a regulatory manager preparing a company for a scheduled Roszdravnadzor inspection, this is not a formality. An outdated reference in an SOP is a direct reason for a finding in an inspection report, and sometimes for an order to remedy a violation.
Below is a breakdown of exactly what has changed, which document is now responsible for what, and what to check in your own procedures right now.
How Two Systems Regulated One Shelf
Starting in March 2017, Russia enforced Ministry of Health Order No. 646n, «On Approval of the Rules of Good Storage and Transportation Practice for Medicinal Products for Medical Use.» The 2016 document covered two processes at once, storage and transportation, and applied to wholesale organizations, pharmacies, and manufacturers within the country.
In parallel, also dating from 2016, there was Decision of the Council of the Eurasian Economic Commission (hereinafter, the EEC) No. 80, «On Approval of the Rules of Good Distribution Practice within the Eurasian Economic Union» (hereinafter, the EAEU, the Union). It regulated the same distribution activity, but at the level of all five member states of the Union: Armenia, Belarus, Kazakhstan, Kyrgyzstan, and Russia.
Both acts required temperature mapping of warehouses, cold chain control, and documentation of deviations. The wording diverged, though, on several significant points.
Decision No. 80 introduced a distinct role: the Responsible Person. This role came with a job description, a defined area of authority, and the right to decide on returned, recalled, or suspected falsified products. Order No. 646n did not single out such a role separately. Responsibility typically fell to the head of the organization or the warehouse manager as part of their regular duties, with no job description written specifically for Good Distribution Practice.
Requirements for computerized monitoring systems diverged too. The Union decision required validating such systems before use, controlling access by user, and keeping backup data for at least 5 years. The national order was limited to general requirements for measuring instruments and logbooks, and left the retention period for records to the discretion of the organization’s head, subject to general archival law.
For a carrier operating only within Russia, the double regulation meant a redundant set of procedures: documentation had to be kept under two standards at once, and an inspector had to be told which one applied in a given situation. For a carrier taking cargo across the border, things were harder still. In Kazakhstan or Belarus, national Order No. 646n did not apply at all, while the Union decision applied uniformly everywhere. The same shipment of a temperature-sensitive drug could formally be subject to different mapping requirements on different legs of a single route.
What Is Left of Order No. 646n After May 2025
An end to the duplication came with Order of the Ministry of Health of Russia dated 11 April 2025, No. 191n. It declared Order No. 646n void as of 31 May 2025. The Ministry of Justice registered the document on 20 May 2025, and it took effect 10 days after official publication, as the procedure for acts of this kind requires.
In place of one all-purpose order, two documents with separate areas of responsibility appeared.
Storage of medicinal products for medical use within the country has, since 1 September 2025, been regulated by Order of the Ministry of Health of Russia dated 29 April 2025, No. 260n, «On Approval of the Rules for Storage of Medicinal Products for Medical Use.» It remains in force until 1 September 2031 and, at the same time, repealed two older acts: Order No. 706n of 2010 and Order No. 1221n, which had amended it.
Transportation and distribution, including movement between countries of the Union, are now governed entirely by Decision No. 80. There is no longer a separate national act for this. A carrier consults one document regardless of whether the cargo travels within Russia or into a neighboring EAEU country.
The transition was not instantaneous. Until 1 September 2025, the old Order No. 706n continued to apply to hospital pharmacies not engaged in retail sales. For pharmacy organizations that do sell at retail, storage and transportation were governed until the same date by Order No. 647n, «On Approval of the Rules of Good Pharmacy Practice.» From 1 September 2025, both transitional documents stopped applying, and the system settled into two independent tracks: storage under Order No. 260n, transportation and distribution under Decision No. 80.
There are substantive changes within storage itself, too. Order No. 260n eased the rules on storing goods together in pharmacy areas: related goods explicitly listed in Part 7, Article 55 of Federal Law No. 61-FZ, including medical devices and hygiene products, may now be kept alongside medicinal products. Previously, this was more often left to an inspector’s discretion than settled by a direct rule.
| Parameter | Order No. 260n (storage, RF) | Decision No. 80 (distribution, EAEU) |
|---|---|---|
| Scope | Storage within Russia | Storage, transportation, and distribution across all countries of the Union |
| Responsible Person | Not designated separately; the head of the organization is responsible | Mandatory role, with a job description and the right to decide the disposition of returned or suspect products |
| Temperature mapping | Required; repeated when equipment or premises change | Required; repeated based on a risk assessment |
| Computerized systems | General requirements for measuring instruments and logbooks | Detailed requirements for validation, access control, and backup copies |
| Record retention | At the head of the organization’s discretion, subject to Law No. 125-FZ on archival affairs | At least 5 years for documentation and backup copies |
| Transportation | Outside the scope of this order | A dedicated section: cold chain, cross-docking, cold packs, carrier contracts |
| Term | In force until 1 September 2031 | Indefinite, subject to later amendments |
Who Now Works Under Which Document
Decision No. 80 applies directly to everyone involved in distribution: wholesale trading organizations, manufacturers that distribute their own output, and any other party in the supply chain, regardless of ownership form or departmental affiliation. For the wholesale tier, this means two documents apply at once, but their subject matter no longer overlaps: storage under Order No. 260n, everything else (transportation, acceptance, handling claims and returns, self-inspections) under Decision No. 80.
Pharmacy organizations that dispense medicines to the public sit in a separate position. Retail dispensing does not fall within the meaning of distribution under Decision No. 80, so for them the main storage document remains Order No. 260n, including the allowance mentioned above for storing related goods together. Medical organizations that use medicinal products in patient care rather than for resale also fall under Order No. 260n for storage.
Manufacturers keep a dual track: manufacturing requirements for storing raw materials and finished products come from Decision of the EEC Council No. 77 on Good Manufacturing Practice, and Decision No. 80 takes over once the product is handed to a distributor or shipped directly to another Union country.
Validating Equipment Without a Shared Vocabulary
Both documents require confirming that warehouse and transport equipment performs predictably, but neither one sets out the four-stage qualification scheme familiar from international practice: design, installation, operational, and performance qualification (DQ, IQ, OQ, and PQ). Decision No. 80 frames this through risk assessment instead: an organization decides for itself which equipment and processes require qualification and validation, then backs up the result with a report explaining any deviations.
In practice, checking a refrigerated truck or a climate chamber still tends to get broken into these same four stages, since it is easier to split responsibility between the equipment supplier, the engineering team, and the warehouse that way. In an SOP, it is more accurate to cite paragraphs 50 and 51 of Decision No. 80 than the abbreviations the document itself never uses.
What Makes the Cross-Border Leg Harder
Controlling temperature inside a single warehouse is simpler than doing it along a route that crosses two or three borders. Decision No. 80 requires the need for temperature control to be assessed against the risks of a specific route, not a general rule applied to every shipment alike. For a run through the climate zones between southern Russia and northern Kazakhstan, that means a separate calculation, not the warehouse’s mapping method copied over.
Cross-docking is a separate concern: transferring cargo from one vehicle to another without extended storage. The rules require minimizing the time cargo spends in the transfer zone and confirming that the zone itself holds the required temperature range for as long as the cargo sits there. For temperature-sensitive medicines, there is an added requirement for cold packs: they must not touch the medicinal product directly, and staff need training in preparing insulated containers with the season in mind.
Decision No. 80 separately requires notifying the transport company of the transportation requirements and signing a contract with it that covers the terms of any outsourced work. A missing clause of this kind in a carrier contract is a common finding during self-inspections, especially when the contract predates 2025 and still cites the repealed Order No. 646n, or does not address temperature control as a separate condition at all.
General Pharmacopoeial Monograph OFS.1.1.0037, «Transportation of Medicinal Products,» adds requirements on cargo identification, protection against contamination, and confirming packaging integrity at delivery. It belongs in the same package as Decision No. 80 when preparing transportation SOPs, not off to the side as a secondary document.
The rules also require physically isolating products suspected of falsification from other goods, starting at acceptance or during transportation, before a regulator makes a decision. For cross-border routes, that means having an isolated area not just at the warehouse of origin but at any intermediate storage point along the way.
Differing levels of digitalization among the Union’s countries add a further practical complication. Russia runs a mandatory serialization (marking) system for medicinal products, while its EAEU partners are at different stages of rolling out comparable traceability systems. When cargo crosses a border, data on its movement is not always transferred automatically into the receiving country’s system, and logistics staff end up re-entering some of it by hand. Decision No. 80 does not address this gap directly, but it does require that the information on the medicinal product in the shipping documents match what was recorded at acceptance, whichever monitoring system is used on a given leg of the route.
What to Do
Check the references in your SOPs and contracts. Find every document that mentions Order No. 646n and replace it with Order No. 260n for storage procedures or Decision No. 80 for transportation and distribution. Separately confirm that no references remain to the transitional Orders No. 706n and No. 647n, which stopped applying on 1 September 2025.
Confirm that a Responsible Person is appointed and documented. Check for a job description that lists their powers, including the right to decide on returned, recalled, and suspected falsified products.
Review the temperature-mapping methodology for both warehouses and transport. Make sure mapping is repeated when equipment or routes change, and that results are kept, together with backup copies of monitoring data, for at least 5 years.
Update carrier contracts. Add the transportation conditions, a procedure for reporting temperature deviations, and an action plan for suspected falsification.
Run a self-inspection under Section 8 of Decision No. 80. Document the results in writing and pass the report to management. This is the item most often skipped between two external audit cycles, and it is usually the first thing a Roszdravnadzor inspector asks about.
A system in which storage and transportation are governed by two separate documents instead of one all-purpose act looks more complicated at first glance than the one it replaced. In practice, it removes the main source of confusion of the past few years: the need to reconcile two acts whose wording did not always match on the same requirement. For cross-border logistics, that means a single source of rules instead of two. It is worth going through SOPs and contracts once, to close the book on Order No. 646n and its transitional companions for good.
Regulatory Framework
1. General Pharmacopoeial Monograph OFS.1.1.0037, «Transportation of Medicinal Products»
2. Decision of the EEC Council dated 3 November 2016, No. 80, «On Approval of the Rules of Good Distribution Practice within the Eurasian Economic Union»
3. Order of the Ministry of Health of Russia dated 29 April 2025, No. 260n, «On Approval of the Rules for Storage of Medicinal Products for Medical Use»
4. Order of the Ministry of Health of Russia dated 11 April 2025, No. 191n, «On Recognizing as Void the Order of the Ministry of Health of the Russian Federation dated 31 August 2016, No. 646n»
5. Federal Law dated 12 April 2010, No. 61-FZ, «On the Circulation of Medicines»